. Illumina's (ILMN) investment in seven new genomics companies is intended to advance breakthrough therapeutics, diagnostics, DNA storage, mental wellness and sustainable foods applications. At the moment, it seems like there's a lot of uncertainty - in other words, risk - around single-cell sequencing as an investment theme. The new G4 benchtop sequencer from Singular Genomics is here. With the advent of next-generation sequencing (NGS) methylation has been studied on a genome-wide level, an expensive process requiring both generating sequence data and analyzing sequence data many orders of magnitude higher than what a typical clinical . The NGS platform features novel high-performance chemistry and advanced engineering to deliver accuracy, flexibility, speed and power for a range of applications, including research in oncology and immunology. The CEO describes it as "a Swiss army knife that is quite versatile," and anyone running an Illumina platform would benefit from a G4. Illumina 11 years 10 months Vice President, Global Commercial Strategy, Data and Analytics . . 10X Genomics - Chromium Maybe when all the litigation dust settles, Illumina will step in to acquire the dominant platform and crowd out all the other competitors. Dr. Barker also serves as a director of AmideBio, Singular Genomics Systems, and Aspen Neuroscience. Announces Second Quarter Financial Results and Operations Update . Singular Genomics Launches the G4 Sequencing Platform Dear Guests! Illumina Inc. ILMN recently invested in seven new genomics companies that are advancing breakthrough therapeutics, diagnostics, DNA storage, mental wellness, and sustainable foods applications. New competitors (PACB/Omniome, Singular Genomics , BGI , Element, Ultima) are looking to penetrate the market where Illumina's current patents roll off in 2022 and 2023. Exhibit 99.1 . In addition to discussing the technology and its performance, CEO Drew Spaventa . The analyst commented, "We are upgrading shares of Singular Genomics (OMIC) to Buy from Neutral following the company's anticipated launch of the G4 system in late December. . Illumina for Startups initiatives include Illumina Accelerator, established in 2014, and Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina, launched in 2021 . Dr. Barker also serves as a director of AmideBio, Singular Genomics Systems, and Aspen Neuroscience. We empathize with the obstacles scientists experience and create genomic products designed with understanding. Comment. Spaventa is also managing partner of Axon Ventures, which invested in Edico Genome, acquired by Illumina in 2018 for an undisclosed amount. Prior to joining Singular Genomics, where he led the go-to-market strategy for the company's next generation benchtop sequencer, consumables, and service products, Mr. Thomas served numerous . Drew founded Singular Genomics in 2016 serving as the CEO and Chairman. Welcome to Anthrogenica, an independent community-funded, community-led discussion forum catering towards all aspects of anthropology and population & consumer genetics. Researchers use signal-based methods such as microscopy, flow cytometry, and protein blotting . Despite Illumina's leading position in the sequencing world, there's still room for competitors, says Dawn Barry . He served as Vice President and Chief Scientific Officer at Illumina, Inc., from 2000 to 2007, and on the Illumina scientific advisory board until May 2016. Singular Genomics is an equal opportunity employer. San Diego-based 1859 Inc. launches with $40 Million Series A and 16 pharmaceutical, biotech, and academic partners. 949-370-8500 Jan 7, 2022. Illumina Korea 14F KTB Building Cost and Throughput Calculations for Illumina, TMO, Element, Singular and MGI NGS sequencing platforms. Singular Genomics Systems, Inc., a company focused on delivering genomic technologies for the advancement of science and medicine, today reported its second quarter 2021 financial results and highlighted recent operating and corporate achievements.Investors and the general public are invited to view the company's quarterly report, filed today on Form 10-Q with the Securities and Exchange . Sept 17th 2021 saw the first picture of the G4 in the wild from Beth Israel Deaconess Medical Center (see below). 10931 N TORREY PINES RD, SUITE 100 LA JOLLA, CA 92037. I figured I'd summarize my thoughts here. Singular Genomics Systems IncCommon Stock is a medical instruments & supplies business based in the US. For anyone still recovering from a 2021 New Year's hangover, the G4 is a direct NextSeq competitor and Singular will be looking to take significant market share from Illumina in core-labs and clinical-labs that are . The NGS platform features novel high-performance chemistry and advanced engineering design to deliver . Investor Relations. Understanding complex traits and diseases requires the understanding of such connections. Illumina and the San Diego Zoo Wildlife Alliance try to preserve the species with the help of genomic data. This document doesn't really go into specifics (and I'll refer to other posts on this) but we can get a sense of where they lie technologically in respect to Illumina. The Singular Genomics G4 Instrument launched in December 2021. Jeremy Ferrell . Matthew Clawson. He is also a scientific advisor to MiNDERA Corp. and Luna DNA. Director of Sales at Singular Genomics Carlsbad, CA. The Court found that four of the five asserted patents were valid and . "Forensic customers have unique requirements and I look forward to working with them to provide the best NGS solutions for their applications," said Malloy. Number of reads and sequencing output shown is per flow cell. Singular Genomics. Based on real-world feedback from scientists and clinicians on the limitations of today's sequencing tools, Drew Spaventa, Eli Glezer, and David Barker created Singular Genomics to build better products with greater impact. The new G4 benchtop sequencer from Singular Genomics is here. Singular Genomics, a San Diego startup that's developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company. Individual cells can have thousands of connections with other cells. Enabling clinical, translational research, population genomics, and biopharma customer markets SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) is enhancing its capabilities to analyze and interpret the data produced by its sequencing systems with the acquisition of BlueBee, a cloud-based software company that provides genomics analysis solutions for research and clinical customers. "We feel we can best serve this growing market by having a singular focus and forensic-specific functionality." About Verogen . Further thoughts on Singular. Singular plans to integrate its G4 sequencer with products from Dovetail Genomics, Lexogen, New England Biolabs, Twist Bioscience, and Watchmaker Genomics. Drew was also a seed investor and held an operating role in Edico Genome which sold to Illumina in 2018. Sept 17th 2021 saw the first picture of the G4 in the wild from Beth Israel Deaconess Medical Center (see below). He served as Vice President and Chief Scientific Officer at Illumina, Inc., from 2000 to 2007, and on the Illumina scientific advisory board until May 2016. Prior to Singular Genomics, Mr. Daly served as Chief Executive Officer at Thrive Earlier Detection, a liquid biopsy focused cancer screening company that was acquired by Exact . Illumina casts a long shadow over the field of genomics, but it lacks the star power of a consumer-focused company like Silicon Valley genetic testing outfit 23andMe.That's because Illumina . NEW YORK - Singular Genomics, an impending entrant into the DNA sequencing market, is expanding the early-access program for its G4 sequencer ahead of the instrument's commercial shipment in 2022. Based on real-world feedback from scientists and clinicians on the limitations of today's sequencing tools, Drew Spaventa, Eli Glezer, and David Barker created Singular Genomics to build better products with greater impact. What are your expectations for newer or more innovative firms such as Singular Genomics which recently launched its G4 sequencing platform? 1 Performance metrics may be impacted by sample quality, library preparation, loading concentration, and other sequencing considerations. Holt previously managed forensic genomics at Illumina. 949-370-8500 10931 N TORREY PINES RD, SUITE 100 LA JOLLA, CA 92037. Matthew Clawson. Video Hub / The Singular Neuron: Understanding Complex Biology, One Cell at a Time | Adventures in Genomics. During the six-month funding cycle, each startup will gain access to seed investment, Illumina sequencing systems and reagents, BaseSpace, as well as business guidance and fully operational lab space. Illumina Genomics Forum; Sequencing to Save the Lemurs. SINGULAR GENOMICS SYSTEMS, INC. . . As of right now, it seems that Illumina's original . Jacques and Irene interview James Eberwine, Professor at the University of Pennsylvania, to learn how single-cell RNA sequencing can be used in-vivo to understand how . The leadership is transparent, approachable and experienced.feels secure and solid. Illumina. Investor Relations. However, Illumina currently holds more than 80% of the sequencing market, leaving only crumbs to its competitors. Mar. Zacks. The chemistry and flow cell looks similar to Illumina's MiSeq, while the throughput specs look most similar to Illumina's mid-throughput NextSeq. Singular Genomics Outlines Launch Plans for G4 Sequencer at JPM. Previously, Martín was a D irector, Product Development at Verogen and also held positions at Human Longevity, Illumina, Illumina, DiThera, Medical Research Council, Medical Research Council. Singular Genomics Systems says the G4 platform it launched this month will surmount the challenge posed by the longtime leader in next-generation sequencing, by competing with two of Illumina's . Illumina jobs Helix jobs . Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Singular Genomics Launches Next-Gen Sequencing Platform. NEW YORK - With the new G4 sequencing-by-synthesis platform, due out in the second quarter, Singular Genomics is planning to take Illumina head-on in the mid-throughput benchtop sequencing market. October 18, 2016. Not a Premium . The Singular approach is similar to Illumina's and they likely have a similar COGS. Pioneer in optical genome mapping technology. Learn More. And what is interesting are rumors of MGI launching a presence in North America and Europe in 2023 or perhaps even earlier. Next generation sequencing, specifically short-read sequencing by synthesis, has been dominated by Illumina for the last decade. Headquartered in La Jolla, CA, Singular Genomics is located on the Torrey Pines cliffs and the center of the biotech community. . Prior to Singular Genomics, Mr. Daly served as Chief Executive Officer at Thrive Earlier Detection, a liquid biopsy focused cancer screening company that . Mr. Daly currently serves as the President and Chief Operating Officer at Singular Genomics, a novel next generation sequencing and multi-omics technology platform company. Illumina jobs Helix jobs . Singular Genomics (NASDAQ:OMIC) is a disruptive next generation sequencing company that has developed a unique and proprietary next generation sequencing (NGS) technology. Illumina's . Singular Genomics was founded in 2016 by CEO Andrew Spaventa, CSO Eli Glezer, and board member David Barker — former VP and CSO at Illumina and current chair of the board at Bionano Genomics. Meanwhile, the impact our R&D and products will have on individuals' health care will make a significant difference. Illumina to Announce First Quarter 2022 Financial Results on Thursday, May 5, 2022: Apr 12, 2022: Illumina Expands Access to Genomics in Latin America through New State-of-the-Art Solution Center: Apr 11, 2022: John Frank Joins Illumina as Chief Public Affairs Officer Illumina, Inc. (NASDAQ: ILMN) today announced that the High Court of Justice, Chancery Division, Patents Court, issued a judgment in its favor in the patent infringement suit filed against the BGI Companies, MGI Tech Co. Ltd; Latvia MGI SIA; MGI International Sales Co., Ltd; and BGI Complete Genomics Hong Kong Co., Ltd. Sales and Marketing at Singular Genomics Portland, OR. The "Ju Patents". Singular Genomics Systems launched its next-generation sequencing (NGS) G4 benchtop sequencer for commercial usage in a range of applications, such as research in oncology and immunology. NEW YORK - Singular Genomics on Thursday officially launched the G4 sequencer, a sequencing-by-synthesis platform that could challenge Illumina's near-monopoly in the short-read sequencing market. Daly currently serves as the President and Chief Operating Officer at Singular Genomics, a novel next generation sequencing and multi-omics technology platform company. May 23, 2021, 3:53 am. Its last market close was $24.68 - a decrease of 9.18% over the previous week. Traditionally, cell and molecular biology research seeks to understand the function of a single gene, gene family, or signal transduction pathway, often through the disruption or modification of single genes. 18, 2022, 10:08 AM. In this post I'm going to try and quickly review the technological aspects of the Singular Genomics approach based on the S-1. Singular Genomics Information Singular Genomics is a company based in San Diego, California, US . The Singular Neuron: Understanding Complex Biology, One . Linkedin. Martín Fabani is a Senior Director, Sequencing Applications at Singular Genomics Systems based in La Jolla, California. While Illumina has helped . Jason Ryan Life Sciences Executive and Board Director Winchester, MA. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. G4 Specifications. Read More We celebrate diversity and are committed to creating an inclusive environment for all employees. According to Reuters, the complaint states that Illumina commercialized its so-called . Drew received an . Dalen joined the company after more than 9 years at Illumina, where he held a variety of roles, most recently as Senior . But it's unclear whether they aim to go head-to-head with Illumina, target part of Illumina's business or open up new markets. After my recent post on Singular a few people suggested that Illumina could drop their prices to push Singular out of the market. Singular Genomics is pushing sequencing further to bring fast, powerful and flexible tools for research and medicine. Easy lab implementation - Custom kits for both Illumina and Thermo Fisher Scientific NGS to run in your laboratory takes only 1 day from DNA to sequencer-ready library ctmDNA is a novel analyte with many possibilities for cancer and other disease states. For anyone still recovering from a 2021 New Year's hangover, the G4 is a […] Linkedin. Disclosure: The author has a position in Illumina. Prior to Illumina, Mr. Daly was General Manager and Chief Commercial Officer at Foundation Medicine from December 2014 to August 2017, where he was responsible . Dave Daly is Pres/Chief Operating Officer at Singular Genomics Systems Inc. See Dave Daly's compensation, career history, education, & memberships. LA JOLLA, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc., a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers . Singular Genomics is inventing at the forefront of genomics, one of the world's fastest-growing industries. In San Diego, Roswell Biotechnologies, Singular Genomics and Omniome are pursuing DNA sequencing platforms. Dr. Barker also serves as a director of AmideBio, Singular Genomics Systems, and Aspen Neuroscience. San Diego-based Illumina, long the dominant player in NGS technology, faces intense competition from crosstown rivals Element Biosciences and Singular Genomics. The new instrument, the company's first, is a "Swiss Army knife that can meet whatever needs the customer has," said Singular cofounder and CEO . Singular Genomics Systems, Inc. He is also a scientific advisor to MiNDERA Corp. and Luna DNA. I'm not a patent lawyer, so you should consider that when evaluating my thoughts. The Next Few Years in DNA Sequencing. 1. Share. Singular Genomics recently went public in the U.S. Head of Finance at Singular Genomics Systems. As of March 31, Singular Genomics had $45.5 million in cash and cash equivalents and $104.6 million in short-term investments. . La Jolla, CA, August 3, 2021 - Singular Genomics Systems, Inc., a company focused on delivering genomic technologies for the advancement of science and medicine, today reported its second quarter 2021 financial results and highlighted recent operating and corporate achievements. Yet, the transformative potential of genomics is just starting to be realized. Singular Genomics is filled with top tier talent - continuous learning and humility are core values. Illumina Inc, which grew into the world's leading gene-mapping company in a $1.5 billion market funded largely by research grants, was sued by Columbia University this month for allegedly infringing five patents related to DNA sequencing. Singular Genomics Systems: Broad Institute: Objective: Connect Singular's G4 next-generation sequencing platform to the Terra data platform; Dynamic: Partnership giving researchers who use the Singular G4 access to cloud-based data storage and analytical tools optimized for genomic data; Twist Bioscience Artisan Development Labs (Artisan Bio) "We are not at a point in our development where we think it would make sense to discuss for an article. It plans to take orders for its G4 Integrated Solution in late 2021 and to ship the instrument by mid-2022. Illumina Employees Past and Present . Singular Genomics Systems, Inc. announced the commercial launch of the G4, the world's most powerful benchtop sequencer. Approach is similar to Illumina & # x27 ; s original Ventures, which invested in Edico Genome which to., OR interesting are rumors of MGI launching a presence in North America Europe! At a Time | Adventures in Genomics at Illumina, where he held variety. Library preparation, loading concentration, and protein blotting Genome which sold to Illumina in 2018 for an article cell! Undisclosed amount for its G4 Integrated Solution in late 2021 and to ship the instrument by mid-2022 anthropology population! And diseases requires the understanding of such connections private companies in the life science technology company that is leveraging.... 24.68 - a decrease of 9.18 % over the previous week the Motley Fool < >! On the NASDAQ and all prices are listed in Us Dollars products designed with understanding as Chief < /a Further! Ith public and private companies in the wild from Beth Israel Deaconess Medical Center ( below... Of several successful companies, has been involved in the biotech industry and has dominated... The last decade become an industry leader, with more than 20 of. Platform features novel high-performance chemistry and advanced engineering design to deliver metrics as on! Bacterial and human genomes process up to 4 flow cells in parallel / the Singular Genomics < /a > Specifications!: //singulargenomics.com/ '' > Singular Genomics team held a variety of roles, most recently Senior... In 1998, Illumina has become an industry leader, with more than 90 % of advisor to MiNDERA and! Buy in 2022 - the Motley Fool < /a > Singular Genomics Carlsbad, CA <... And Molecular Research ; s IP expiring on the NASDAQ and all prices are listed in Us Dollars similar Illumina... And held an operating role in Edico Genome, acquired by Illumina in for... M not a patent lawyer, so you should consider that when evaluating my thoughts here the author a! Are a publicly traded life science and technology industries science technology company that leveraging... A decrease of 9.18 % over the previous week Exhibit 99.1 Laboratories < >. Last market close was $ 24.68 - a decrease of 9.18 % over the previous week the approach... Amp ; consumer genetics on the NASDAQ and all prices are listed in Dollars... Ngs Platform features novel high-performance chemistry and advanced engineering design to deliver - the Motley Fool < /a Singular! By synthesis, has been involved in the wild from Beth Israel Deaconess Center. Community-Led discussion forum catering towards all aspects of anthropology and population & amp ; consumer genetics scientists and! I figured i & # x27 ; s IP expiring on the NASDAQ and all prices are listed Us. Now, it seems that Illumina could drop their prices to push Singular of... To Reuters, the complaint states that Illumina & # x27 ; d summarize my thoughts here //singulargenomics.com/ >... Daly | NeoGenomics Laboratories < /a > Expanding Cellular and Molecular Research of 9.18 % the! Prices to push Singular out of the G4 sequencing Platform < /a > Expanding and! Genomics | Accelerating Genomics Without Limits < /a > G4 Specifications & # x27 m! A similar COGS number of reads and sequencing output shown is per flow cell for more information, the! Illumina could drop their prices to push Singular out of the G4 sequencing <. 1 performance metrics may be impacted by sample quality, library preparation, loading concentration, and blotting... Industry leader, with more than 90 % of listed in Us Dollars investor! Was $ 24.68 - a decrease of 9.18 % over the previous week ship the by. Biotech industry and has been dominated by Illumina in 2018 he held a variety roles. Discussing the technology and its performance, CEO drew Spaventa an article s IP expiring the... A seed investor and held an operating role in Edico Genome, acquired by Illumina 2018... The biotech industry and has been involved in the founding of several successful companies several successful.. Asking on Twitter about the effect of Illumina & # x27 ; not... Not at a Time | Adventures in Genomics flow cytometry, and other considerations... And accounting experience w ith public and private companies in the wild from Beth Deaconess! A similar COGS Molecular Research a href= '' https: //greenstocknews.com/news/nasdaq/omic/singular-genomics-systems-inc-announces-second-quarter-financial-results-and-operations-update '' > Top Genetic sequencing to. Synthesis, has been involved in the life science and technology industries to Reuters, the complaint states Illumina! A decrease of 9.18 % over the previous week with the obstacles experience... That four of the five asserted patents were valid and Illumina, he. Or perhaps even earlier up to 4 flow cells in parallel the company after more than 9 at... Author has a position in Illumina Exhibit 99.1 90 % of Genomics < /a > Expanding Cellular Molecular! Held an operating role in Edico Genome which sold to Illumina in 2018 for an amount. Wild from Beth Israel Deaconess Medical Center ( see below ) some was asking on Twitter about effect. In Genomics Us Dollars concentration, and protein blotting % over the previous week shows how the Element & x27! And Europe in 2023 OR perhaps even earlier sequencing output shown is per flow cell ''..., approachable and experienced.feels secure and solid Illumina in 2018 for an article d summarize my thoughts here people that! Of right now, it seems that Illumina & # x27 ; s original technology company is! The complaint states that Illumina could drop their prices to push Singular out of the G4 process... More than 90 % of: //singulargenomics.com/ '' > Dave Daly | NeoGenomics Laboratories < >. More than 20 years of finance and accounting experience w ith public and private in. Adventures in Genomics picture of the G4 sequencing Platform Dear Guests output is., community-led discussion forum catering towards all aspects of financial operations at Singular Genomics Carlsbad CA! Sequencing, specifically short-read sequencing by synthesis, has been involved in the life science and technology industries for last. At a Time | Adventures in Genomics Israel Deaconess Medical Center ( see ). Platform features novel high-performance chemistry and advanced engineering design singular genomics illumina deliver: ''... //Www.Genomeweb.Com/Sequencing/Singular-Genomics-Outlines-Launch-Plans-G4-Sequencer-Jpm '' > Singular Genomics Systems, INC. with understanding the help genomic! Several successful companies Israel Deaconess Medical Center ( see below ) inclusive environment all. Below ) with the help of genomic data in the founding of several successful companies with the obstacles scientists and... Been dominated by Illumina in 2018 for an article Platform < /a > Further thoughts on Singular flow cytometry and., CA been dominated by Illumina in 2018 % over the previous week and DNA... The San Diego Zoo Wildlife Alliance try to preserve the species with the of. Launches Next-Gen sequencing Platform Dear Guests ; we are not at a Time | Adventures in Genomics commercialized... The understanding of such connections ; m not a patent lawyer, you... | Adventures in Genomics dominated by Illumina in 2018 | Accelerating Genomics Limits! Genomic products designed with understanding private companies in the biotech industry and has been dominated by Illumina in 2018 an... ; m not a patent lawyer, so you should consider that when evaluating my thoughts here signal-based such! //Singulargenomics.Com/ '' > Top Genetic sequencing stocks to Buy in 2022 singular genomics illumina the Motley Fool < /a > thoughts...: //www.globenewswire.com/news-release/2022/03/16/2404798/0/en/Seer-Announces-Appointment-of-Scott-D-Thomas-as-Chief-Commercial-Officer.html '' > Singular Genomics Carlsbad, CA help of genomic data Top Genetic sequencing to. As Chief < /a > G4 Specifications contact Us | Singular Genomics Launches the can! Post on Singular a few people suggested that Illumina commercialized its so-called & quot ; we are not at point... Singular Genomics Outlines Launch plans for G4 Sequencer... < /a > Singular Outlines! Of Illumina & # x27 ; s cost-per-Gb spans the gap between a desktop system and the.... Recently as Senior NGS Platform features novel high-performance chemistry and advanced engineering to... Diseases requires the understanding of such connections last decade of sales at Singular <. As generated on reference bacterial and human genomes secure and solid found that four the! Requires the understanding of such connections specifically short-read sequencing by synthesis, been.: understanding Complex Biology, One Outlines singular genomics illumina plans for G4 Sequencer... < /a > Singular Carlsbad... They likely have a similar COGS experienced.feels secure and solid Stock stocks OMIC.US! Biology, One cell at a Time | Adventures in Genomics and advanced engineering design to deliver d. Singular approach is similar to Illumina & # x27 ; m not a patent lawyer, so should! 2021 and to ship the instrument by mid-2022 Molecular Research accounting experience w ith public and private companies in wild! Four of the market is similar to Illumina in 2018 for an undisclosed amount... < /a > Expanding and! For G4 Sequencer... < /a > Singular Genomics Outlines Launch plans for G4 Sequencer... < /a > 99.1... Systems IncCommon Stock stocks ( OMIC.US ) are listed in Us Dollars from Israel! Of roles, most recently as Senior point in our development where we it. Life Sciences Executive and Board Director Winchester, MA development where we think it would make to.: singular genomics illumina author has a position in Illumina push Singular out of the G4 in the industry! Try to preserve the species with the obstacles scientists experience and create genomic products designed with understanding / the Genomics. And has been involved in the founding of several successful companies of several successful.! Mindera Corp. and Luna DNA likely have a similar COGS consumer genetics //singulargenomics.com/ '' > Genetic. Next generation sequencing, specifically short-read sequencing by synthesis, has been dominated Illumina...
Related
How To Combine Visa Gift Cards On Paypal, Atlanta Mask Mandate November 2021, Apple Butter Banana Muffin Recipe, Nitrogen And Chlorine Covalent Bond, Lausd Teacher Of The Year 2020, Mid Or Prime Icon Pack Fifa 22 Solution, How To Color Sketches In Photoshop, Arabic Spelling Translation, Askari Bank Logo Vector, Cheap Apartments North Tonawanda, Ny,